Jury Hands Down a Verdict in Prevagen Deceptive Marketing Case
Verdict comes nine years after TINA.org alerted regulator to supplement’s unsubstantiated health claims.
In September 2019, a class-action lawsuit was filed against JB7, LLC for allegedly deceptively marketing its Physician’s Choice Collagen Peptides as “the ultimate sports and post recovery protein” and that each serving of the product provides 12 percent of the Daily Value of protein when, according to the complaint, the Daily Value percentage for the product is zero because it is missing one of the nine essential amino acids (tryptophan) and thus is an “incomplete protein.” (McLaughlin et al v. JB7, LLC, Case No. 19-cv-23748, S. D. FL.)
Verdict comes nine years after TINA.org alerted regulator to supplement’s unsubstantiated health claims.
Grab your bag now, before Dina & Mita do
Regulators have a beef with company’s climate pledge.
Consumers need to be wary of undisclosed incentivized reviews.
Why TINA.org supports FTC’s proposed changes to COPPA Rule but pushes for more.